Jazz Pharmaceuticals to tap bank loans for $1.5 billion Celator buyout

By Susanna Moon

Chicago, May 31 – Jazz Pharmaceuticals plc said it plans to use borrowings under its senior secured credit facility to finance its $1.5 billion acquisition of Celator Pharmaceuticals, Inc.

Jazz also will use cash on hand, according to a company press release.

Jazz is a Dublin-based pharmaceutical company. Celator Pharmaceuticals, Inc. is a pharmaceutical company based in Ewing, N.J.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.